Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
International Journal of Cancer|May 8, 2023
Pan-cancer efficacy and safety of anlotinib plus PD-1 inhibitor in refractory solid tumor: A single-arm, open-label, phase II trialBao-Dong Qin, Xiao-Dong Jiao, Zhan Wang, et al.
Nature Communications|May 31, 2025
Anlotinib plus toripalimab as a first-line treatment in patients with advanced gastric cancer and performance status 2: the phase II APICAL-GC trialKe Liu, Bao-Dong Qin, Shi-Qi Chen, et al.
Oncology Reports|March 2, 2021
Low microRNA150 expression is associated with activated carcinogenic pathways and a poor prognosis in patients with breast cancerSan-Qi An, Ke He, Fei Liu, et al.
The Oncologist|July 1, 2025
Impact of Molecular Tumor Board on Clinical Outcomes in Patients with Refractory Solid Tumor: a Real-World StudyYan Ling, Xiao-Dong Jiao, Bao-Dong Qin, et al.
Signal Transduction and Targeted Therapy|September 15, 2025
Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trialZhan Wang, Bao-Dong Qin, Chen-Yang Ye, et al.
Pageof 2